Published online Dec 24, 2017. doi: 10.5500/wjt.v7.i6.324
Peer-review started: November 5, 2017
First decision: November 20, 2017
Revised: November 27, 2017
Accepted: December 5, 2017
Article in press: December 6, 2017
Published online: December 24, 2017
Processing time: 47 Days and 18.1 Hours
The definitive treatment for end stage liver disease remains a liver transplant and hence livers are needed for these patients along with cases of acute fulminant liver failure. Hence livers are a scarce and highly valuable commodity in the current time. By extending the pool of donors to include the elderly livers, it allows for increased availability of donors and reduces the mortality that is associated with the waiting list itself. There is an increasing prevalence of end stage liver disease due to conditions like chronic hepatitis B and C, non-alcoholic steatohepatitis, alcoholic liver disease. Many studies show non-inferior outcomes when elderly livers are used as a vigorous selection process is implemented. The process takes into account the characteristics of the donor, graft and recipient allowing for appropriate donor-recipient coupling. To meet the increasing demands of livers, elderly donors should be utilized for liver transplantation. The aim of this review article is to describe the aging process of the liver and the outcomes associated with use of elderly livers for transplantation.
Core tip: There is an increasing demand of livers for transplantation. Several studies showed successful results with elderly donors. We reviewed the aging process of the liver and the transplant outcomes of elderly donors. We highlight that elderly donors can be utilized given the extensive screening process allowing for risk factor analysis and appropriate allocation. Hence they should be used to allow for treatment of liver disease globally and help mitigate the shortage of hepatic grafts.